SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?


To: Jibacoa who wrote (78)10/21/2002 1:13:39 PM
From: Jibacoa  Respond to of 3722
 
QSC Is up 15.56% today with volume more than half its daily volume.

There has been significant insider and institutional buying lately and the company announced last week that the AMEX gave them up to eighteen months to regain compliance with the "continued listing standards".

The OBV on its daily chart has remained relatively low since its double bottom in July this year, but relatively high on its weekly chart since the L of 0.38 in April 2001 <g>

siliconinvestor.com

siliconinvestor.com

siliconinvestor.com

Bernard



To: Jibacoa who wrote (78)10/22/2002 11:10:38 PM
From: Jibacoa  Read Replies (1) | Respond to of 3722
 
JNJ and the coated stent market.

Well in spite of closing to the downside today, it is likely that JNJ will bounce back tomorrow after an FDA advisory panel today unanimously endorsed its Sirulimus-coated stent.

JNJ said they expect approval of their Cypher stent by the end of the first Q in 2003.

Analysts predict that the drug-coated stents will double the size of the overall coronary stent market to $5 billion.

It is expected that J&J will be alone in the drug-coated stent market for a full year because BSX is not expected to bring its paclitaxel-coated stent to the U.S. market before the end of 2003.JNJ is already marketing its Cypher stent in Europe.

biz.yahoo.com

siliconinvestor.com

siliconinvestor.com

BSX has been outperforming JNJ and GDT in the last 3 months.

siliconinvestor.com

Bernard